COVID-associated non-vasculitic thrombotic retiform purpura of the face
and extremities: A case report
- Connor Bunch,
- Nuha Zackariya,
- Anthony Thomas,
- Jack Langford,
- Michael Aboukhaled,
- Samuel Thomas,
- Aida Ansari,
- Shivani Patel,
- Hallie Buckner,
- Joseph Miller,
- Christy Annis,
- Margaret Quate-Operacz,
- Leslie Schmitz,
- Joseph Pulvirenti,
- Jonathan Konopinski,
- Kathleen Kelley,
- Samer Hassna,
- Luke Nelligan,
- Mark Walsh
Nuha Zackariya
Indiana University School of Medicine-South Bend
Author ProfileAnthony Thomas
Indiana University School of Medicine-South Bend
Author ProfileJack Langford
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileMichael Aboukhaled
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileSamuel Thomas
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileAida Ansari
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileShivani Patel
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileHallie Buckner
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileChristy Annis
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileJoseph Pulvirenti
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileSamer Hassna
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileLuke Nelligan
Marian University College of Osteopathic Medicine
Author ProfileMark Walsh
Saint Joseph Regional Medical Center Mishawaka Campus
Author ProfileAbstract
SARS-CoV-2 infection can manifest many rashes. However, thrombotic
retiform purpura rarely occurs during COVID-19 illness. Aggressive
anti-COVID-19 therapy with a high-dose steroid regimen led to rapid
recovery. This immuno-thrombotic phenomenon likely represents a poor
type 1 interferon response and complement activation on the endothelial
surface in response to acute infection.12 Oct 2022Submitted to Clinical Case Reports 12 Oct 2022Submission Checks Completed
12 Oct 2022Assigned to Editor
18 Oct 2022Reviewer(s) Assigned
20 Nov 2022Review(s) Completed, Editorial Evaluation Pending
20 Nov 2022Editorial Decision: Revise Minor
28 Nov 20221st Revision Received
29 Nov 2022Submission Checks Completed
29 Nov 2022Assigned to Editor
29 Nov 2022Review(s) Completed, Editorial Evaluation Pending
08 Dec 2022Editorial Decision: Accept
